Thrive Wealth Management LLC reduced its holdings in Xylem Inc. (NYSE:XYL – Free Report) by 4.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,512 shares of the industrial products company’s stock after selling 260 shares during the quarter. Thrive Wealth Management LLC’s holdings in Xylem were worth $640,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. State Street Corp raised its stake in shares of Xylem by 1.9% in the third quarter. State Street Corp now owns 10,329,494 shares of the industrial products company’s stock worth $1,394,792,000 after acquiring an additional 189,820 shares during the last quarter. Geode Capital Management LLC increased its holdings in shares of Xylem by 1.0% in the third quarter. Geode Capital Management LLC now owns 5,668,755 shares of the industrial products company’s stock valued at $762,804,000 after purchasing an additional 54,877 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its position in Xylem by 1.0% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 3,449,307 shares of the industrial products company’s stock worth $465,760,000 after purchasing an additional 32,645 shares during the last quarter. Swedbank AB lifted its holdings in Xylem by 22.8% during the 3rd quarter. Swedbank AB now owns 2,991,583 shares of the industrial products company’s stock worth $403,953,000 after buying an additional 554,609 shares in the last quarter. Finally, Impax Asset Management Group plc boosted its position in Xylem by 1.0% in the 3rd quarter. Impax Asset Management Group plc now owns 1,677,816 shares of the industrial products company’s stock valued at $226,555,000 after buying an additional 15,825 shares during the last quarter. 87.96% of the stock is owned by institutional investors and hedge funds.
Xylem Stock Performance
Shares of Xylem stock opened at $119.84 on Monday. Xylem Inc. has a 12 month low of $109.70 and a 12 month high of $146.08. The company has a current ratio of 1.96, a quick ratio of 1.42 and a debt-to-equity ratio of 0.19. The company has a market capitalization of $29.11 billion, a PE ratio of 35.04, a PEG ratio of 1.89 and a beta of 1.06. The stock’s fifty day simple moving average is $121.08 and its 200 day simple moving average is $128.77.
Xylem Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, December 24th. Stockholders of record on Tuesday, November 26th were issued a $0.36 dividend. The ex-dividend date of this dividend was Tuesday, November 26th. This represents a $1.44 dividend on an annualized basis and a dividend yield of 1.20%. Xylem’s dividend payout ratio (DPR) is presently 42.11%.
Analyst Ratings Changes
A number of equities research analysts have recently weighed in on the company. Stifel Nicolaus dropped their target price on Xylem from $172.00 to $166.00 and set a “buy” rating for the company in a research report on Wednesday, December 11th. Wolfe Research restated a “peer perform” rating on shares of Xylem in a research report on Thursday, December 12th. Robert W. Baird lowered their price target on shares of Xylem from $175.00 to $154.00 and set an “outperform” rating for the company in a research report on Friday, November 1st. TD Cowen reduced their price objective on shares of Xylem from $138.00 to $125.00 and set a “hold” rating on the stock in a research note on Wednesday, November 6th. Finally, Royal Bank of Canada dropped their target price on shares of Xylem from $163.00 to $162.00 and set an “outperform” rating for the company in a research report on Friday, November 1st. Three equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $152.10.
Read Our Latest Stock Analysis on Xylem
About Xylem
Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.
Recommended Stories
- Five stocks we like better than Xylem
- What Are Growth Stocks and Investing in Them
- Earn High Dividends With 2 Top REITs Set to Perform in 2025
- Want to Profit on the Downtrend? Downtrends, Explained.
- Oilfield Leader SLB: An AI Name You Need to Know
- What is the S&P 500 and How It is Distinct from Other Indexes
- Top ETFs That Beat the Market in 2024 and Could Do It Again
Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYL – Free Report).
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.